{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:15:54Z","timestamp":1788552954050,"version":"build-2803163510"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.colsurfb.2026.116100","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:11Z","timestamp":1787067851000},"page":"116100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Unlocking exosome potential: Comprehensive review on diagnostic, prognostic and therapeutic approaches in melanoma"],"prefix":"10.1016","volume":"268","author":[{"given":"Aashi","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Chaure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annu","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerana","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.colsurfb.2026.116100_bib1","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib2","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/acsabm.5c00077","article-title":"Harnessing folate receptors: a comprehensive review on the applications of folate-adorned nanocarriers for the management of Melanoma","volume":"8","author":"Sahane","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.colsurfb.2026.116100_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2026.116100_bib4","unstructured":"Cancer Today, 2022, IARC Cancer Today GLOBOCAN 2022 Report (accessed October 6, 2025)https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie-prevalence?mode=population&cancers=16&key=total&sort_by=value1&group_populations=0&values_position=0&types=2."},{"key":"10.1016\/j.colsurfb.2026.116100_bib5","first-page":"591","article-title":"Mortality Trends and Projections \u2014 United States, 1982\u20132030","volume":"64","author":"Guy","year":"2015","journal-title":"Cent. Dis. Control. Prev. (CDC) Vital. Signs Melanoma Incid."},{"key":"10.1016\/j.colsurfb.2026.116100_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101617","article-title":"Nanotechnology addressing cutaneous melanoma: The italian landscape","volume":"13","author":"Battaglia","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.116100_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113282","article-title":"Unveiling the potential of inorganic nanoarchitecture-mediated photothermal therapy: An illustration on melanoma","volume":"216","author":"Hedaoo","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.colsurfb.2026.116100_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1534735421990078","article-title":"Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma","volume":"20","author":"Sood","year":"2021","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114205","article-title":"Hyaluronic acid-infused microneedles: Unlocking the revolutionary era of targeted melanoma treatment","volume":"238","author":"Sahane","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.colsurfb.2026.116100_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-981-99-8373-5_14","article-title":"Exosomes as a Future Diagnostic Tool for Brain Disorders","author":"Bhawale","year":"2024","journal-title":"Exosomes Based Drug. Deliv. Strateg. Brain Disord."},{"key":"10.1016\/j.colsurfb.2026.116100_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1201\/9781003623632-8","article-title":"Harnessing Exosomes for the Development of Next-Generation Cancer Vaccines","author":"Sahane","year":"2026","journal-title":"Exosome Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116100_bib13","first-page":"1","article-title":"Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2026.116100_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109320","article-title":"Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma","volume":"113","author":"Alia Moosavian","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116100_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01278-3","article-title":"Exosome-based immunotherapy: a promising approach for cancer treatment","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2023.100032","article-title":"Exosome as drug delivery system: Current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.colsurfb.2026.116100_bib17","article-title":"Recent advances in exosome-based drug delivery for cancer therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fsufs.2019.00023","article-title":"Naturally Occurring Exosome Vesicles as Potential Delivery Vehicle for Bioactive Compounds","volume":"3","author":"Akuma","year":"2019","journal-title":"Front. Sustain. Food Syst."},{"key":"10.1016\/j.colsurfb.2026.116100_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189238","article-title":"Exosomes as a Therapeutic Strategy in Cancer: Potential Roles as Drug Carriers and Immune Modulators","volume":"1880","author":"Abedi","year":"2025","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib20","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1021\/acsabm.5c00955","article-title":"Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to Bedside","volume":"8","author":"Vasave","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.colsurfb.2026.116100_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.55038","article-title":"Lipid accumulation controls the balance between surface connection and scission of caveolae","volume":"9","author":"Hubert","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.colsurfb.2026.116100_bib22","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.colsurfb.2026.116100_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semcdb.2017.08.022","article-title":"Biogenesis and function of ESCRT-dependent extracellular vesicles","volume":"74","author":"Juan","year":"2018","journal-title":"Semin. Cell. Dev. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib25","doi-asserted-by":"crossref","first-page":"e1004742","DOI":"10.1371\/journal.ppat.1004742","article-title":"Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and Function","volume":"11","author":"Diaz","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.colsurfb.2026.116100_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ceb.2009.06.002","article-title":"Cell biology of the ESCRT machinery","volume":"21","author":"Hanson","year":"2009","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib27","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.devcel.2011.05.015","article-title":"The ESCRT Pathway","volume":"21","author":"Henne","year":"2011","journal-title":"Dev. Cell."},{"key":"10.1016\/j.colsurfb.2026.116100_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020175","article-title":"Focus on extracellular vesicles: New frontiers of cell-to-cell communication in cancer","volume":"17","author":"Ciardiello","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib31","article-title":"Bro1 stimulates Vps4 to promote intralumenal vesicle formation during multivesicular body biogenesis","volume":"220","author":"Tseng","year":"2021","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib32","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1242\/dev.098178","article-title":"Heparan sulfate proteoglycans: A sugar code for vertebrate development?","volume":"142","author":"Poulain","year":"2015","journal-title":"Development (Cambridge)"},{"key":"10.1016\/j.colsurfb.2026.116100_bib33","doi-asserted-by":"crossref","first-page":"17380","DOI":"10.1073\/pnas.1304266110","article-title":"Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity","volume":"110","author":"Christianson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2026.116100_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan-syntenin-ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cell.2015.10.017","article-title":"Relaxation of Loaded ESCRT-III Spiral Springs Drives Membrane Deformation","volume":"163","author":"Chiaruttini","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2026.116100_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/boc.201500010","article-title":"Syntenin and syndecan in the biogenesis of exosomes","volume":"107","author":"Friand","year":"2015","journal-title":"Biol. Cell."},{"key":"10.1016\/j.colsurfb.2026.116100_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/jcm9020436","article-title":"Inclusion Biogenesis, Methods of Isolation and Clinical Application of Human Cellular Exosomes","volume":"9","author":"Tschuschke","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.colsurfb.2026.116100_bib38","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M112.445304","article-title":"The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes","volume":"288","author":"Perez-Hernandez","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.116100_bib39","first-page":"75","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib40","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.18632\/oncotarget.24846","article-title":"Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity","volume":"9","author":"Tucci","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2026.116100_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105697","article-title":"Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer","volume":"151","author":"Biswal","year":"2023","journal-title":"Arch. Oral. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib42","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1002\/cam4.5698","article-title":"Role of tumor microenvironment in cancer progression and therapeutic strategy","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.colsurfb.2026.116100_bib43","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.3390\/ijms21165840","article-title":"Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers","volume":"21","author":"Olejarz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib44","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1002\/jcp.26202","article-title":"Horizontal transfer of miR-23a from hypoxic tumor cell colonies can induce angiogenesis","volume":"233","author":"Sruthi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib45","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1038\/onc.2017.105","article-title":"Hypoxic lung cancer-secreted exosomal MIR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1","volume":"36","author":"Hsu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.colsurfb.2026.116100_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0970-x","article-title":"Therapy resistance mediated by exosomes","volume":"18","author":"Steinbichler","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/cancers15010080","article-title":"Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment","volume":"15","author":"Ye","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/cas.13109","article-title":"Wnt5b-associated exosomes promote cancer cell migration and proliferation","volume":"108","author":"Harada","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tips.2016.04.006","article-title":"Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance","volume":"37","author":"Syn","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2026.116100_bib53","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib54","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib55","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116100_bib56","doi-asserted-by":"crossref","first-page":"R663","DOI":"10.1530\/ERC-18-0019","article-title":"The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer","volume":"25","author":"Alharbi","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drup.2018.01.002","article-title":"Redundant angiogenic signaling and tumor drug resistance","volume":"36","author":"Gacche","year":"2018","journal-title":"Drug. Resist. Updates"},{"key":"10.1016\/j.colsurfb.2026.116100_bib58","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.stemcr.2017.04.024","article-title":"MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer","volume":"8","author":"Godlewski","year":"2017","journal-title":"Stem Cell. Rep."},{"key":"10.1016\/j.colsurfb.2026.116100_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2026.116100_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2019.07.003","article-title":"Exosomes and their role in tumorigenesis and anticancer drug resistance","volume":"45","author":"Milman","year":"2019","journal-title":"Drug. Resist. Updates"},{"key":"10.1016\/j.colsurfb.2026.116100_bib61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neo.2017.07.002","article-title":"Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle\u2013Associated PDGFR\u03b2","volume":"19","author":"Vella","year":"2017","journal-title":"Neoplasia (U. S. )"},{"key":"10.1016\/j.colsurfb.2026.116100_bib62","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"issue":"22:1","key":"10.1016\/j.colsurfb.2026.116100_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12964-024-01906-1","article-title":"Exosome-based immunotherapy as an innovative therapeutic approach in melanoma","volume":"2024","author":"Babaei","year":"2024","journal-title":"Cell. Commun. Signal."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116100_bib64","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00403-025-04237-4","article-title":"Exosomes as key mediators in immune and cancer cell interactions: insights in melanoma progression and therapy","volume":"317","author":"Hsu","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.colsurfb.2026.116100_bib65","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1021\/acsnano.4c09190","article-title":"Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.116100_bib66","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2214\/AJR.11.6797","article-title":"Molecular theranostics: A primer for the imaging professional","volume":"197","author":"Lee","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/nnm.09.59","article-title":"Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications","volume":"4","author":"Lapotko","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2026.116100_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70658","article-title":"Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma","volume":"16","author":"Li","year":"2026","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.colsurfb.2026.116100_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CJI.0b013e3181fe535b","article-title":"Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: A critical role of interferon-\u03b3","volume":"34","author":"Viaud","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.colsurfb.2026.116100_bib70","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1021\/acs.molpharmaceut.4c00490","article-title":"Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin","volume":"21","author":"Kumar","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116100_bib71","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.ymthe.2023.06.005","article-title":"An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112586","article-title":"Cell-derived artificial nanovesicle as a drug delivery system for malignant melanoma treatment","volume":"147","author":"Lin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2026.116100_bib73","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.apsb.2025.04.013","article-title":"Engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma immunotherapy","volume":"15","author":"Zhao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2026.116100_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152636","article-title":"Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes","volume":"16","author":"Kulkarni","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.colsurfb.2026.116100_bib75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2018.07.067","article-title":"Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model","volume":"549","author":"Shamili","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116100_bib76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clindermatol.2012.08.016","article-title":"Chemotherapy in the Management of Advanced Cutaneous Malignant Melanoma","volume":"31","author":"Luke","year":"2013","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/psb.2.1.3596","article-title":"Do Plant Cells Secrete Exosomes Derived from Multivesicular Bodies?","volume":"2","author":"An","year":"2007","journal-title":"Plant. Signal. Behav."},{"key":"10.1016\/j.colsurfb.2026.116100_bib78","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1039\/D3TB02752J","article-title":"Plant-derived exosomes: a green approach for cancer drug delivery","volume":"12","author":"Madhan","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.116100_bib79","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/med.21564","article-title":"Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study","volume":"39","author":"Tao","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.colsurfb.2026.116100_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2025.130776","article-title":"Study on the activity of targeted delivery of DOX against melanoma by exosome-like nanovesicles of Rhodiola rosea","volume":"1869","author":"Xu","year":"2025","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.colsurfb.2026.116100_bib81","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/acsabm.1c00413","article-title":"Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics","volume":"4","author":"Walia","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.colsurfb.2026.116100_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13259","article-title":"Adriamycin-loaded exosome with anti-CD20 aptamers selectively suppresses human CD20+ melanoma stem cells","volume":"29","author":"Chen","year":"2023","journal-title":"Skin. Res. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib83","doi-asserted-by":"crossref","first-page":"42411","DOI":"10.1021\/acsami.1c10325","article-title":"Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy","volume":"13","author":"Jiang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.116100_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: A Potential Natural Anticancer Drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib85","article-title":"Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin","volume":"99","author":"Kumar","year":"2024","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib86","first-page":"297","article-title":"Nanotechnology-mediated combinational drug delivery approach for cancer therapy","author":"Handa","year":"2022","journal-title":"Comb. Drug. Deliv. Approach Eff. Ther. Var. Dis."},{"key":"10.1016\/j.colsurfb.2026.116100_bib87","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1021\/acsbiomaterials.4c00856","article-title":"Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives","volume":"10","author":"Ahmed","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.colsurfb.2026.116100_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biomaterials.2016.09.031","article-title":"Exosome-based tumor antigens\u2013adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA","volume":"111","author":"Morishita","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.116100_bib89","article-title":"Nanosponge-mediated oligonucleotide delivery: A cutting-edge technology towards cancer management","author":"Khairnar","year":"2023","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biomaterials.2016.09.031","article-title":"Exosome-based tumor antigens\u2013adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA","volume":"111","author":"Morishita","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.116100_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1403021","article-title":"Immunotherapy in melanoma: advances, pitfalls, and future perspectives","volume":"11","author":"Sorino","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib92","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT Gene Mutations and Copy Number in Melanoma Subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.116100_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-017-3691-7","article-title":"The Advantages and Challenges of Using FDG PET\/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy","volume":"44","author":"Wong","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.colsurfb.2026.116100_bib94","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1021\/acsami.4c10804","article-title":"Harnessing Spatiotemporal-Specific Tumorous Exosome Dynamics: Ultra-Sensitive Lanthanide Luminescence Detection Strategy Enabled by Exosomal Membrane Engineering for Melanoma Immunotherapy Monitoring","volume":"16","author":"Zhu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.116100_bib95","article-title":"Impact of Radiation on Exosomes in Regulating Tumor Immune Microenvironment","volume":"9","author":"Yu","year":"2024","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/OTT.S20257","article-title":"Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents","volume":"4","author":"Khan","year":"2011","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib97","article-title":"Innovative approaches in precision radiation oncology: advanced imaging technologies and challenges which shape the future of radiation therapy","volume":"12","author":"Yan","year":"2025","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.colsurfb.2026.116100_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-031-18810-7_6","article-title":"Radiobiology of Combining Radiotherapy with Other Cancer Treatment Modalities","author":"Ahire","year":"2023","journal-title":"Radiobiol. Textb."},{"key":"10.1016\/j.colsurfb.2026.116100_bib99","doi-asserted-by":"crossref","first-page":"46705","DOI":"10.1021\/acsami.5c10385","article-title":"Ex Vivo High-Dose Ionizing Irradiation-Conditioned Nanovesicles for Enhancing the Immune Effects of Tumor Radiotherapy","volume":"17","author":"Yang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.116100_bib100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/cancers7010353","article-title":"Proton Radiobiology","volume":"7","author":"Tommasino","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib101","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.6","article-title":"Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair","volume":"24","author":"Nikitaki","year":"2022","journal-title":"Expert. Rev. Mol. Med."},{"key":"10.1016\/j.colsurfb.2026.116100_bib102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2020.06.016","article-title":"Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell\u2013Dependent Mechanism","volume":"108","author":"Jella","year":"2020","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.colsurfb.2026.116100_bib103","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2013.08.035","article-title":"Combinations of Radiotherapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes","volume":"88","author":"Barker","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.colsurfb.2026.116100_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-025-03281-2","article-title":"Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects","volume":"44","author":"Rafiq","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.116100_bib105","article-title":"Engineering Autologous Cell-Derived Exosomes to Boost Melanoma-Targeted Radio-Immunotherapy by Cascade cGAS-STING Pathway Activation","volume":"21","author":"Zhang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2026.116100_bib106","article-title":"Harnessing peptide-based nanotherapeutics: Pioneering melanoma management from diagnosis to theranostics","volume":"107","author":"Shukla","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128452","article-title":"Supramolecular self-assembled peptide-engineered nanofibers: A propitious proposition for cancer therapy","volume":"256","author":"Pandey","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142158","article-title":"Harnessing marine antimicrobial peptides for novel therapeutics: A deep dive into ocean-derived bioactives","volume":"307","author":"Kanaujia","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib109","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.7150\/jca.100840","article-title":"Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126077","article-title":"Nano-biohybrids with cell-penetrating peptides: A molecular trojans for glioblastoma precision medicine","volume":"683","author":"Phatale","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116100_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01597-1","article-title":"\u03b1v\u03b23 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma","volume":"20","author":"Gu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib112","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-024-03512-0","article-title":"M1 macrophage-derived exosomal microRNA-29c-3p suppresses aggressiveness of melanoma cells via ENPP2","volume":"24","author":"An","year":"2024","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.colsurfb.2026.116100_bib114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40425-019-0580-6","article-title":"The clinical application of cancer immunotherapy based on naturally circulating dendritic cells","volume":"7","author":"Bol","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2026.116100_bib115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/bs.ircmb.2019.08.005","article-title":"Dendritic cell extracellular vesicles","volume":"349","author":"Kowal","year":"2019","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.imlet.2012.07.006","article-title":"Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro","volume":"148","author":"Marton","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.colsurfb.2026.116100_bib117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CJI.0b013e3181fe535b","article-title":"Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: A critical role of interferon-\u03b3","volume":"34","author":"Viaud","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.colsurfb.2026.116100_bib118","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/DDDT.S414758","article-title":"Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy","author":"Lin","year":"2023","journal-title":"Drug. Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2026.116100_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib120","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3390\/cancers13153667","article-title":"DC-Derived Exosomes for Cancer Immunotherapy","volume":"13","author":"Yao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib121","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21037\/atm.2017.02.23","article-title":"Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges","volume":"5","author":"Tian","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.colsurfb.2026.116100_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep17622","article-title":"TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma","volume":"5","author":"Damo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2026.116100_bib123","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/cancers13061363","article-title":"Targeting NK Cells to Enhance Melanoma Response to Immunotherapies","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib124","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1158\/0008-5472.CAN-12-1181","article-title":"Melanoma cells inhibit NK cell functions - Letter","volume":"72","author":"Sconocchia","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.116100_bib125","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells","volume":"284","author":"Parolini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2026.116100_bib126","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","article-title":"Immune Surveillance Properties of Human NK Cell-Derived Exosomes","volume":"189","author":"Lugini","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CJI.0000000000000082","article-title":"Engineering NK cells modified with an EGFRvIII-specific chimeric antigen receptor to overexpress CXCR4 improves immunotherapy of CXCL12\/SDF-1\u03b1-secreting glioblastoma","volume":"38","author":"M\u00fcller","year":"2015","journal-title":"J. Immunother."},{"key":"10.1016\/j.colsurfb.2026.116100_bib128","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.7150\/thno.18752","article-title":"Exosomes derived from natural killer cells exert therapeutic effect in melanoma","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.116100_bib129","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.3390\/ijms22189726","article-title":"The Role of Melanoma Cell-Derived Exosomes (MTEX) and Photodynamic Therapy (PDT) within a Tumor Microenvironment","volume":"22","author":"Mkhobongo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib130","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.3390\/ijms25137292","article-title":"Modifications of Nanobubble Therapy for Cancer Treatment","volume":"25","author":"Terlikowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116100_bib131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib132","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4324-2023220572","article-title":"Improved Antiproliferative Activity of Doxorubicin-Loaded Calcium Phosphate Nanoparticles Against Melanoma Cells","volume":"66","author":"Lima","year":"2023","journal-title":"Braz. Arch. Biol. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib133","article-title":"Targeted theranostic oxygen-filled and doxorubicin-loaded mesenchymal stem cell-derived exosomes-based-nanobubble against melanoma","volume":"105","author":"Bagheri","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.116100_bib134","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-3659(01)00488-6","article-title":"Clinical aspects of drug delivery to tumors","volume":"78","author":"Jessie","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2026.116100_bib135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/cancers9040036","article-title":"Cancer Chemotherapy Specific to Acidic Nests","volume":"9","author":"Kobayashi","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.116100_bib136","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.canlet.2014.10.017","article-title":"Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma","volume":"356","author":"Azzarito","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2026.116100_bib137","first-page":"205","article-title":"Acridine Orange could be an Innovative Anticancer Agent under Photon Energy","volume":"21","author":"Kusuzaki","year":"2007","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.colsurfb.2026.116100_bib138","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/ol_00000012","article-title":"In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model","volume":"1","author":"Satonaka","year":"2010","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.colsurfb.2026.116100_bib139","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/14756366.2017.1292263","article-title":"Acridine orange\/exosomes increase the delivery and the effectiveness of acridine orange in human melanoma cells: A new prototype for theranostics of tumors","volume":"32","author":"Iessi","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.colsurfb.2026.116100_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.colsurfb.2026.116100_bib141","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1039\/D4NA00501E","article-title":"A comprehensive review of challenges and advances in exosome-based drug delivery systems","volume":"6","author":"Palakurthi","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.colsurfb.2026.116100_bib142","unstructured":"n.d., Engineering quality control into biomanufacturing of extracellular vesicle-based products | FDA (accessed October 11, 2025)https:\/\/www.fda.gov\/science-research\/advancing-regulatory-science\/engineering-quality-control-biomanufacturing-extracellular-vesicle-based-products."},{"key":"10.1016\/j.colsurfb.2026.116100_bib143","article-title":"Welsh, Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"J.A","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.colsurfb.2026.116100_bib144","unstructured":"ICH Q5C Stability testing of biotechnological\/biological products - Scientific guideline | European Medicines Agency (EMA), (n.d.https:\/\/www.ema.europa.eu\/en\/ich-q5c-stability-testing-biotechnological-biological-products-scientific-guideline(accessed October 11, 2025).."},{"key":"10.1016\/j.colsurfb.2026.116100_bib145","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2488551","article-title":"Past, present, and future of exosomes research in cancer: A bibliometric and visualization analysis","volume":"21","author":"Xie","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.colsurfb.2026.116100_bib146","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.2147\/IJN.S417422","article-title":"Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases","volume":"18","author":"Zou","year":"2023","journal-title":"Int. J. Nanomed."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526006880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:52:21Z","timestamp":1788551541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526006880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":146,"alternative-id":["S0927776526006880"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116100","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking exosome potential: Comprehensive review on diagnostic, prognostic and therapeutic approaches in melanoma","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116100"}}